MedTrace Logo

Flavonoid-rich Supplement Influence on the Human Metabolome

NCT03004742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2017-02-02

No results posted yet for this study

Summary

This study will measure the effect of ingesting a flavonoid-rich supplement on various biomarkers in overweight/obese women during a 12-week period. The flavonoid-rich supplement contains a mixture of flavonoids including quercetin, catechins from green tea extract, and anthocyanins from bilberry extract, and other food components that facilitate flavonoid bioactivity including fish oil, caffeine, and vitamin C.

Conditions

Interventions

DIETARY_SUPPLEMENT

Flavonoid

Flavonoid rich supplement

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Reoxcyn Discoveries Group

    collaborator UNKNOWN

  • Appalachian State University

    lead OTHER

Principal Investigators

  • David C Nieman, DrPH · Appalachian State Univ

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004742 on ClinicalTrials.gov